Short answer

Even when the active molecule is the same, its registration as a medicine or as a dietary supplement is a fundamentally different world. A medicine goes through clinical trials, GMP-standard manufacturing, mandatory pharmacovigilance, and strict dose and purity control. A dietary supplement is registered as a food product, clinical trials are not required, and the package may list one amount of active ingredient while the capsule contains something else. When a compound has an evidence base and is available as a medicine, choosing a supplement loses on every count except price and over-the-counter availability.

Why this conversation matters

At a Russian pharmacy counter a patient rarely sees a principled difference: «Akvadetrim» (vitamin D medicine) and «Detrimax» (vitamin D supplement) sit on the same shelf. Both contain cholecalciferol. The supplement is often cheaper and OTC. The difference seems to be only in the wrapping.

In reality the difference is that a medicine must prove safety, efficacy, and composition stability before reaching the market. A supplement does not – it registers under food-product rules. That cascades into a long list of distinctions that rarely fit on a label.

This article is not about «supplements are all bad». It is about how a good active compound loses most of its clinical value once it is placed into a supplement form. If there is a choice – medicine or supplement – the clinically correct answer is almost always the same.

What is a medicine and what is a supplement in law

Medicines in Russia are regulated by Federal Law 61 «On the circulation of medicinal products». Registration requires preclinical studies, three phases of clinical trials for efficacy and safety, GMP-compliant manufacturing, batch quality control, and inclusion in the ГРЛС registry. Advertising is tightly controlled.

Supplements in Russia are regulated by the Customs Union technical regulations TR TS 021/2011 and TR TS 027/2012 – food-product legislation. Registration results in a «State Registration Certificate» issued by Rospotrebnadzor. Only safety under recommended dose is required; clinical efficacy trials are not. Production follows food-standard GMP, weaker than pharmaceutical GMP. Advertising is formally restricted but relies heavily on implicit «for heart health» or «immune support» claims.

In the US medicines are regulated by the FDA under the Federal Food, Drug, and Cosmetic Act with mandatory clinical trials and GMP. Supplements are regulated by DSHEA 1994: manufacturers do not have to prove safety or efficacy before market entry. The FDA intervenes only after signals of harm – the regulator is reactive.

Real failures of the supplement industry – specific numbers

Herbal supplements and DNA barcoding. Newmaster SG et al. BMC Medicine 2013 analysed 44 herbal supplements from 12 Canadian manufacturers using DNA barcoding. Result: 59 % of products contained DNA of plant species not listed on the label; 33 % had the labelled species replaced by another; 32 % contained undisclosed fillers (wheat, rice, soybeans). In 44 % of samples the labelled main ingredient was absent from DNA analysis.

Melatonin – label vs reality. Erland LA, Saxena PK. J Clin Sleep Med 2017 analysed 31 melatonin brands in Canada. Actual content relative to label ranged from –83 % to +478 %. One capsule could contain 6 times more or 5 times less than printed.

Omega-3 – EPA and DHA standardisation. Kleiner AC et al. J Nutr Sci 2014 tested 171 fish oil brands. The labelled EPA+DHA amount was reached in only 25 % of samples. In the other 75 % actual content was 10–80 % below label.

Probiotics – live bacteria count. Marcobal A et al. Gastroenterology 2008 tested 14 commercial probiotic brands. Labelled strain composition matched reality in 43 %. In the others some strains were absent, some were present below therapeutic counts, and some were unlabelled strains.

Heavy-metal contamination. Saper RB et al. JAMA 2008 tested 193 Ayurvedic supplements purchased online and in US pharmacies. 20.7 % contained detectable lead, mercury, or arsenic, with some samples exceeding FDA safe daily doses by tens to hundreds of times.

Undeclared pharmacological agents. Pieter Cohen (Harvard Medical School) has published a series on supplement adulteration. Pre-workout supplements contained DMAA, DMBA, BMPEA, octopamine after FDA bans. «Natural» sexual-enhancement supplements contained sildenafil and tadalafil at undisclosed doses. Weight-loss supplements contained sibutramine and phenolphthalein. The patient believes they take a herbal extract; in fact they receive an undeclared drug at an unknown dose.

Emergency department visits. Geller AI et al. N Engl J Med 2015 reviewed 10 years of US emergency surveillance (2004–2013). Supplements caused about 23,000 ED visits per year – mostly from cardiovascular events with stimulant products and hepatotoxic herbals.

On specific molecules

Vitamin D. Cholecalciferol as a molecule is identical in any form. The difference lies in concentration stability. Prescription Akvadetrim passed ГРЛС registration with bioavailability and purity control – 500 IU per drop with pharmacy-level accuracy. OTC supplement Detrimax 2000 registered as a supplement at a stated dose of 2000 IU per tablet. In trials meta-analyses use a standardised cholecalciferol. The clinical effect belongs to that standardised form. Supplement with the same dose may produce different serum 25(OH)D due to bioavailability differences.

Omega-3. Omacor (medicine) contains 84 % EPA+DHA as ethyl esters. It is the form used in large RCTs (REDUCE-IT, STRENGTH, OMEMI). A common fish oil supplement contains 18–40 % EPA+DHA, with 60–82 % being other fatty acids including saturated. Achieving a therapeutic 4 g EPA+DHA daily requires 4 Omacor capsules or 12–25 supplement capsules without a clear dosing guide.

Iron. Prescription Sorbifer Durules contains 100 mg elemental iron as sulfate with controlled release. Maltofer contains 100 mg as polymaltose. Supplement «Iron chelate» contains 18–45 mg elemental iron as bisglycinate with unspecified release kinetics. WHO and BSG recommend 100–200 mg elemental iron daily for anaemia – 1–2 tablets of medicine vs 4–11 supplement capsules with uncertainty in actual content.

Melatonin. Prescription Melaxen delivers 3 mg of melatonin per tablet, ГРЛС-registered with bioavailability control. Circadin is EMA-registered at 2 mg prolonged-release for insomnia in adults over 55. Supplement «Evalar Melatonin 3 mg» has been tested independently (Erland 2017) with doses ranging from 2.5 to 14 mg. A 4-fold variance is critical for circadian use.

Probiotics. Prescription Linex has standardised Lactobacillus acidophilus, Bifidobacterium infantis, Enterococcus faecium with CFU control through shelf life. A supplement with 10–20 strains without specified CFU and thermostabilisation can have near-zero live counts by end of shelf life (Marcobal 2008).

Five supplement traps

Trap 1: «Natural means safe». Natural origin does not guarantee safety. Amanita mushrooms, cyanide from apricot kernels, hepatotoxic alkaloids in greater celandine are all natural. Drug interactions with herbal supplements are documented: St John's wort induces CYP3A4 and reduces efficacy of oral contraceptives, warfarin, antidepressants, immunosuppressants. Ginkgo biloba increases bleeding risk with anticoagulants.

Trap 2: «One capsule with 25 vitamins and minerals». Multivitamin complexes contain dozens of components at sub-clinical doses. For clinical indications (vitamin D, folate, or B12 deficiency) a specific dose of a specific compound is required, not «a bit of everything». Physicians' Health Study II (10 years, 14,641 men) showed no effect of multivitamins on cardiovascular events and a minimal effect on cancer. «For general health» multivitamins are marketing, not treatment.

Trap 3: «Trusted brand – I buy Solgar, so it is fine». Premium international brands do not undergo additional clinical testing. Solgar, NOW Foods, and Thorne register as supplements under DSHEA in the US and as supplements in Russia. Quality systems at large manufacturers are better than at small ones, and independent laboratories (USP, NSF, ConsumerLab) test them more often. But no supplement substitutes for a medicine with a registered clinical effect. Supplement standards are always below medicinal GMP.

Trap 4: «More active ingredient per capsule is better». Supplements often list doses above the daily allowance and above their medicinal counterparts – marketing calls this «more effective». In reality upper safe intake levels are set (IOM/EFSA): vitamin D 4000 IU, vitamin B6 100 mg, zinc 40 mg, iron 45 mg for adults. Exceeding them risks vitamin D toxicity, B6-sensory neuropathy, copper deficiency from zinc, oxidative stress from iron.

Trap 5: «Supplement replaces medicine if the RCT confirmed the effect». The most common and most dangerous logic. Even when a meta-analysis confirms clinical benefit of the active molecule, that effect belongs to the standardised medicinal form tested in the trial. For a supplement with the same molecule but a different salt form, different excipients, and unknown manufacturing quality – extrapolating the RCT result is mathematically incorrect. Citing an RCT on a medicinal capsule as «evidence of efficacy» for a supplement is marketing, not science.

When supplement is OK and when medicine wins

Supplement is a reasonable option when:

  • The goal is to cover a daily requirement of a vitamin or mineral in a healthy person without deficiency or disease (prophylaxis in at-risk dietary groups)
  • Clinical necessity is absent, and the patient wants «general tone» acknowledging the weak or absent evidence base
  • The compound has no medicinal form (for example, hydrolysed collagen, lutein-zeaxanthin)

Medicine beats supplement when:

  • A clinical diagnosis is established (iron deficiency anaemia, vitamin D deficiency, B12 deficiency anaemia, hypertriglyceridaemia)
  • A precise dose is needed for therapeutic effect
  • The patient takes other drugs and interactions must be avoided
  • An evidence link between the formulation and clinical outcome is required
  • The patient has comorbid disease that demands stable active-substance levels

In practice: when a physician makes a diagnosis and prescribes therapy – medicine. When dietary support in an at-risk group is the goal – a supplement is acceptable, chosen by «less is more, reputable manufacturer» without expecting a drug-level effect.

What to check on a supplement label if you choose one

  1. State registration certificate number – mandatory. Absent means the product is sold illegally.
  2. Active ingredient form – bisglycinate, citrate, sulfate. Bioavailability varies.
  3. Amount of elemental substance – «iron – 28 mg», not «iron bisglycinate – 400 mg».
  4. Manufacturer – prefer companies with independent certification (USP Verified, NSF Certified for Sport, ConsumerLab Seal of Approval).
  5. List of other ingredients – shorter is better. A list of 15 herbal extracts «for synergy» is marketing.
  6. Expiration and storage – critical for probiotics and oils.

None of these turn a supplement into a medicine. They allow distinguishing a more responsible supplement from a less responsible one.

Bottom line

The difference between a medicine and a supplement is not in the molecule but in the regulatory frame. A medicine must prove benefit and keep composition stable between batches. A supplement need not. When a patient has a clinical task – treat a deficiency, correct a lab marker, reduce cardiovascular risk – medicine outperforms supplements on every count except price and OTC availability. Even when the active molecule is the same.

There are situations where a supplement is a reasonable compromise: prophylactic vitamin dose in an at-risk dietary group, a compound without a medicinal analogue. But if the medicine is available, it is the first choice.

Sources

  • Newmaster SG et al. DNA barcoding detects contamination and substitution in North American herbal products. BMC Medicine 2013;11:222
  • Erland LA, Saxena PK. Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content. J Clin Sleep Med 2017;13(2):275-281
  • Kleiner AC et al. A comparison of actual versus stated label amounts of EPA and DHA in commercial omega-3 dietary supplements. J Nutr Sci 2014;3:e55
  • Marcobal A et al. Analysis of commercial probiotics for composition and content of active ingredients. Gastroenterology 2008;135(4):1379-1387
  • Saper RB et al. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA 2008;300(8):915-923
  • Cohen PA. The FDA and adulterated supplements. JAMA Intern Med 2018;178(7):881-882
  • Geller AI et al. Emergency Department Visits for Adverse Events Related to Dietary Supplements. N Engl J Med 2015;373:1531-1540
  • Physicians' Health Study II Research Group. Multivitamins in the prevention of cancer in men. JAMA 2012;308(18):1871-1880
  • U.S. FDA. Dietary Supplement Health and Education Act of 1994 (DSHEA)
  • Russian Federal Law 61 «On the circulation of medicinal products»
  • Customs Union Technical Regulation TR TS 021/2011 «On food product safety»

This article is not a substitute for a medical consultation. Any supplement or medicine decision is made individually with a treating clinician.